A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: determined (252), resolute (3)

Fluorouracil-Folinic Acid-Irinotecan-Oxaliplatin

Description
Chemotherapy Protocol PANCREATIC CANCER FLUOROURACIL-FOLINIC ACID-IRINOTECAN-OXALIPLATIN (FOLFIRINOX) This protocol may require funding Regimen • Pancreatic C
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Fluorouracil-Folinic-Acid-Irinotecan-Oxaliplatin.pdf

Cetuximab (7 day)

Description
Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB (7 day) This regimen may require funding Regimen • Colorectal Cancer – Cetuxima
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab7day.pdf

DVdSC (weekly cycles1-8) Bortezomib-Daratumumab-Dexamethasone Ver1

Description
Chemotherapy Protocol Myeloma DVd SC (weekly cycles 1-8) Bortezomib-Daratumumab-Dexamethasone Regimen • Myeloma – DV
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles1-8-Bortezomib-Daratumumab-Dexamethasone-Ver1.pdf

COV001_PIS_v5.0_21_Apr_2020_localised

Description
Southampton NIHR Clinical Research Facility University Hospital Southampton NHS Foundation Trust C Level West Wing, Mailpoin
Url
/Media/Southampton-Clinical-Research/COVID-19/Vaccine-trial/COV001-PIS-v5.0-21-Apr-2020-localised.docx

Aspects of disclosure

Description
In a recent case, the Court of Appeal distinguished clearly the clinician's role in identifying the risks and complications inherent in
Url
/HealthProfessionals/Clinical-law-updates/Aspects-of-disclosure.aspx

Private patient policy

Description
Private Patient Policy Trust reference Description FIN002 Version number 2 This policy provides guidance on how to administer a
Url
/Media/UHS-website-2019/Docs/Policies/Private-patient-policy.pdf

Lenalidomide-RituximabIV/SC

Description
Chemotherapy Protocol LYMPHOMA LENALIDOMIDE-RITUXIMAB (IV/SC) There are multiple versions of this protocol in use. Please ensu
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lenalidomide-RituximabIVSC.pdf

Lenalidomide-Rituximab IV

Description
Chemotherapy Protocol LYMPHOMA LENALIDOMIDE-RITUXIMAB (IV) There are multiple versions of this protocol in use. Please ensure
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lenalidomide-Rituximab-IV.pdf

MyelomaMPTMelphalan(PO)PrednisoloneThalidomideVer1

Description
Chemotherapy Protocol MULTIPLE MYELOMA MPT-MELPHALAN (PO)-PREDNISOLONE-THALIDOMIDE Regimen Multiple Myeloma – MPT-Melphalan (PO)-Prednisolone-Thalidomide Indication First line treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaMPTMelphalanPOPrednisoloneThalidomideVer1.pdf

Binimetinib-Encorafenib

Description
Chemotherapy Protocol SKIN CANCER Binimetinib-Encorafenib Regimen • Skin – Binimetinib-Encorafenib Indication • Unresectab
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Binimetinib-Encorafenib.pdf
171 to 180 of 496
Previous … 16 17 18 19 20 … Next